https://wikimd.org/index.php?action=history&feed=atom&title=NAMI-ANAMI-A - Revision history2026-04-26T22:01:07ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=NAMI-A&diff=5369003&oldid=prevPrab: CSV import2024-03-06T04:43:30Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:NAMI-A.png|thumb|{{PAGENAME}}]]<br>'''NAMI-A''' (Imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate) is a [[ruthenium]]-based [[metallo-drug]] that has been extensively studied for its potential anti-metastatic properties. It is named after the National Institute for the Study of Metals and their Applications (NAMI) in Italy, where it was first synthesized.<br />
<br />
== History ==<br />
NAMI-A was first synthesized in the late 20th century by researchers at the NAMI. The compound was developed as part of a broader effort to explore the potential of [[transition metals]] in the treatment of [[cancer]]. The development of NAMI-A was inspired by the success of [[cisplatin]], a platinum-based drug that has been widely used in cancer treatment.<br />
<br />
== Structure and Properties ==<br />
NAMI-A is a complex of ruthenium with two [[imidazole]] ligands, a [[dimethyl sulfoxide]] (DMSO) ligand, and four [[chloride]] ions. The ruthenium atom is in the +3 oxidation state. The compound is a stable, crystalline solid that is soluble in water and DMSO.<br />
<br />
== Mechanism of Action ==<br />
The exact mechanism of action of NAMI-A is not fully understood. However, it is believed to inhibit the process of [[metastasis]] by interfering with the adhesion, invasion, and proliferation of cancer cells. Unlike cisplatin, NAMI-A does not interact significantly with [[DNA]], suggesting that it operates through a different mechanism.<br />
<br />
== Clinical Trials ==<br />
NAMI-A has undergone several [[clinical trials]] to evaluate its safety and efficacy in the treatment of cancer. These trials have shown promising results, particularly in the treatment of [[lung cancer]] and [[ovarian cancer]]. However, further research is needed to fully understand the potential of this drug.<br />
<br />
== See Also ==<br />
* [[Ruthenium]]<br />
* [[Cisplatin]]<br />
* [[Metastasis]]<br />
* [[Clinical trial]]<br />
<br />
[[Category:Chemotherapy agents]]<br />
[[Category:Ruthenium compounds]]<br />
[[Category:Anti-cancer drugs]]<br />
{{Chem-stub}}<br />
{{Pharma-stub}}</div>Prab